Protective Effect of Galantamine against Doxorubicin-Induced Neurotoxicity

Protective Effect of Galantamine against Doxorubicin-Induced Neurotoxicity

Background and aims: Doxorubicin (DOX) causes cognitive impairment (chemobrain) in patients with cancer. While DOX damages the cholinergic system, few studies have focused on the protective effects of cholinergic function on chemobrain. The acetylcholinesterase inhibitor galantamine (GAL) demonstrat...

Full description

Bibliographic Details
Main Authors: Rawan S. Alsikhan, Maha A. Aldubayan, Ibtesam S. Almami, Ahmad H. Alhowail
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Brain Sciences
Subjects:
doxorubicin
galantamine
neuroinflammation
cognitive impairment
neuroprotective
ELISA
Online Access:https://www.mdpi.com/2076-3425/13/6/971

Internet

https://www.mdpi.com/2076-3425/13/6/971

Similar Items